medical/legal issues in genetic testing : workshop no. 3

2
630 Workshop on Heritable Cancer Syndromes and Genetic Testing Supplement to Cancer Medical/Legal Issues in Genetic Testing Workshop No. 3 Patrick Lynch, J.D., M.D. (Co-Chair) T Matthew Severin, J.D., Ph.D. (Co-Chair) he workgroup considered a number of medical-legal issues in genetic testing, including regulatory issues, legislative issues, Alan Mills (Rapporteur) and emerging standards of patient care that perhaps have, or will, Linda Bosserman, M.D.* represent a ‘‘duty’’ on the part of the physician. These issues Doreine Carson* share a degree of uncertainty as well as a lack of clear and shared Donald C. Chambers, M.D.* standards, and in some instances are driven by competing inter- Myles Cunningham, M.D.* ests. The workgroup participants agreed that there was a pressing May Sung, M.P.H.* Nicholas J. Vogelzang, M.D.* need to further define and explore these issues, especially among competing interests, and that there should be strong collaborative initiatives among appropriate organizations to establish guide- lines to assist the public and providers on issues related to risk assessment and clinical decision making. Recommendations Duties for the Physician/Provider 1. All physicians should take a family history. 2. Providers should have guidelines for recognizing ‘‘at risk’’ individu- als, and responsibility for family reporting. 3. Guidelines for referral for genetic counseling and testing services are needed. 4. ‘‘Gag rules’’ employed by managed care and similar entities, partic- ularly as they apply to predisposition testing and clinical surveil- lance, are inappropriate. Legislative Issues 1. There should be legislative support for training and education to enhance skills in genetic counseling. 2. There should be informed consent standards for genetic testing, and testing should only be offered in the context of pre- and post- * Workshop participant. test counseling. 3. The Americans with Disabilities Act should be amended to include Presented at the American Cancer Society Workshop on Heritable Cancer Syndromes and genetic predisposition. The Equal Employment Opportunity Com- Genetic Testing, Chicago, Illinois, October 7 – 8, mission should prohibit employment discrimination based on ge- 1996. netic predisposition. Address for reprints: Patrick Lynch, J.D., 4. There is a need to support greater access to clinical trials, and state M.D., Department of Gastrointestinal Medical insurance regulations should insure coverage for participants in Oncology and Digestive Diseases, University studies. of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 78, Houston, Regulatory Issues TX 77030. 1. There should be national regulatory mechanisms through the Food and Drug Administration, or other appropriate body, that establish Received April 10, 1997; accepted April 16, 1997. quality assurance standards for genetic testing. q 1997 American Cancer Society / 7b5c$$1221 07-14-97 13:22:01 cana W: Cancer

Upload: patrick-lynch

Post on 06-Jun-2016

216 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Medical/Legal issues in genetic testing : Workshop No. 3

630

Workshop on Heritable Cancer Syndromesand Genetic Testing

Supplement to Cancer

Medical/Legal Issues in Genetic TestingWorkshop No. 3

Patrick Lynch, J.D., M.D. (Co-Chair)

TMatthew Severin, J.D., Ph.D. (Co-Chair)he workgroup considered a number of medical-legal issues ingenetic testing, including regulatory issues, legislative issues,

Alan Mills (Rapporteur)and emerging standards of patient care that perhaps have, or will,Linda Bosserman, M.D.*represent a ‘‘duty’’ on the part of the physician. These issuesDoreine Carson*share a degree of uncertainty as well as a lack of clear and sharedDonald C. Chambers, M.D.*standards, and in some instances are driven by competing inter-Myles Cunningham, M.D.*ests. The workgroup participants agreed that there was a pressingMay Sung, M.P.H.*

Nicholas J. Vogelzang, M.D.* need to further define and explore these issues, especially amongcompeting interests, and that there should be strong collaborativeinitiatives among appropriate organizations to establish guide-lines to assist the public and providers on issues related to riskassessment and clinical decision making.

RecommendationsDuties for the Physician/Provider1. All physicians should take a family history.2. Providers should have guidelines for recognizing ‘‘at risk’’ individu-

als, and responsibility for family reporting.3. Guidelines for referral for genetic counseling and testing services

are needed.4. ‘‘Gag rules’’ employed by managed care and similar entities, partic-

ularly as they apply to predisposition testing and clinical surveil-lance, are inappropriate.

Legislative Issues1. There should be legislative support for training and education to

enhance skills in genetic counseling.2. There should be informed consent standards for genetic testing,

and testing should only be offered in the context of pre- and post-* Workshop participant.

test counseling.3. The Americans with Disabilities Act should be amended to includePresented at the American Cancer Society

Workshop on Heritable Cancer Syndromes and genetic predisposition. The Equal Employment Opportunity Com-Genetic Testing, Chicago, Illinois, October 7–8, mission should prohibit employment discrimination based on ge-1996.

netic predisposition.Address for reprints: Patrick Lynch, J.D., 4. There is a need to support greater access to clinical trials, and stateM.D., Department of Gastrointestinal Medical insurance regulations should insure coverage for participants inOncology and Digestive Diseases, University

studies.of Texas M. D. Anderson Cancer Center,1515 Holcombe Boulevard, Box 78, Houston, Regulatory IssuesTX 77030.

1. There should be national regulatory mechanisms through the Foodand Drug Administration, or other appropriate body, that establishReceived April 10, 1997; accepted April 16,

1997. quality assurance standards for genetic testing.

q 1997 American Cancer Society

/ 7b5c$$1221 07-14-97 13:22:01 cana W: Cancer

Page 2: Medical/Legal issues in genetic testing : Workshop No. 3

Medical and Legal Issues/Lynch 631

Patient Rights2. A national tissue/samples data bank should be1. The American Cancer Society should work withcreated, with appropriate and strict safeguards other organizations to promulgate information on

on the use of materials and information. patient rights with regard to genetic testing.

/ 7b5c$$1221 07-14-97 13:22:01 cana W: Cancer